NASDAQ:ATRA
Atara Biotherapeutics Stock News
$0.700
+0.0390 (+5.90%)
At Close: Mar 27, 2024
Noble Energy Announces Second Quarter Results
12:00am, Monday, 03'rd Aug 2020
Noble Energy, Inc. (NASDAQ: NBL) (“Noble Energy” or the “Company”) today provided second quarter financial and operating results. “Noble Energy's seco
Atara Biotherapeutics to Announce Second Quarter 2020 Financial Results on Wednesday, August 5, 2020
08:01pm, Wednesday, 29'th Jul 2020
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for patients with severe diseases, including sol
The Retiree's Dividend Portfolio - Jane's June Update: Record Dividends During COVID-19
07:58pm, Monday, 27'th Jul 2020
Jane's retirement accounts generated a total of $2,047.11 of dividend income for June 2020 vs. $1,561.04 of dividend income for June of 2019.
IPO Update: AlloVir Proposes Terms For $251 Million IPO
12:18pm, Sunday, 26'th Jul 2020
AlloVir intends to raise $251 million in a U.S. IPO of its common stock.
Atara Biotherapeutics (ATRA) Moves to Buy: Rationale Behind the Upgrade
04:00pm, Tuesday, 21'st Jul 2020
Atara Biotherapeutics (ATRA) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AlloVir Seeks IPO For Anti-Viral Pipeline Development
03:38pm, Thursday, 16'th Jul 2020
AlloVir has filed to raise $100 million in an IPO. The firm is advancing a pipeline of treatments and preventions for various viral diseases, including Covid19.
Assessing If The Bulls Can Gain Control In CenturyLink (NYSE:CTL)
07:56am, Thursday, 09'th Jul 2020
Value and profitability numbers look really attractive in this stock. Cash-flow multiple also looks compelling.
Atara Biotherapeutics Inc (NASDAQ:ATRA) Shares Sold by Victory Capital Management Inc.
04:12am, Sunday, 05'th Jul 2020
Victory Capital Management Inc. lowered its holdings in Atara Biotherapeutics Inc (NASDAQ:ATRA) by 9.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange
Atara Biotherapeutics (NASDAQ:ATRA) Rating Increased to Strong-Buy at BidaskClub
02:30am, Friday, 03'rd Jul 2020
Atara Biotherapeutics (NASDAQ:ATRA) was upgraded by BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Friday, BidAskClub reports. Several other research an
Will Atara Biotherapeutics Continue to Surge Higher?
03:28pm, Wednesday, 01'st Jul 2020
As of late, it has definitely been a great time to be an investor of Atara Biotherapeutics
2 Biotech Stocks That Could Soar in 2020
11:12am, Wednesday, 01'st Jul 2020
Despite the market volatility throughout this year, there are still good prospects in this sector, especially in small-cap biotechnology stocks. If you have cash waiting to be put to work, you might
Atreca (BCEL) Received its Third Buy in a Row - Markets
10:27am, Wednesday, 01'st Jul 2020
After H.C. Wainwright and Cowen & Co. gave Atreca (NASDAQ: BCEL) a Buy rating last month, the company received another
Benzinga's Top Upgrades, Downgrades For June 30, 2020
02:19pm, Tuesday, 30'th Jun 2020
Upgrades * For Crocs Inc (NASDAQ: CROX), Loop Capital upgraded the stock from Hold to Buy. In the first quarter, Crocs showed an EPS of $0.22, compared to $0.36 from the year-ago quarter. The stock
Could AAL, OXY, HOG, COTY, CTL – 5 Debt-Laden Stock Portfolio Actually Score Big?
12:00am, Tuesday, 30'th Jun 2020
What’s common between American Airlines, Centurylink, Coty, Occidental Petroleum, and Harley-Davidson? They are all part of our high leverage portfolio where we advise investors to exercise caution.